Credit Suisse’s ESSA Pharma EPIX Stock Holding History

Credit Suisse’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-22,306	Closed	-$139K	–	4028
2022 Q1	$139K	Buy	22,306 +9,933	+80%	+$87.3K	﹤0.01%	3450
2021 Q4	$176K	Sell	12,373 -1,340	-10%	-$14.9K	﹤0.01%	4303
2021 Q3	$110K	Buy	13,713 +1,487	+12%	+$23.6K	﹤0.01%	4312
2021 Q2	$348K	Buy	+12,226	New	+$355K	﹤0.01%	4039

Other funds holding EPIX

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Credit Suisse's EPIX Position: Q2 2022 in Review

Credit Suisse sold out of ESSA Pharma (EPIX) in Q2 2022, closing a stake of 22,306 shares — an estimated $139K sold.

Credit Suisse first reported a position in EPIX in Q2 2021 and held it in 4 quarters. The position peaked at $348K in Q2 2021. 59 funds tracked by Wall St. Rank hold EPIX as of Q2 2022.

Credit Suisse reported no remaining ESSA Pharma position as of Q2 2022 after selling out during the quarter.
Credit Suisse sold 22,306 ESSA Pharma shares in Q2 2022, an estimated $139K.
Credit Suisse first reported a position in ESSA Pharma in Q2 2021 and held it in 4 quarters.
Credit Suisse's ESSA Pharma position peaked at $348K in Q2 2021.
59 funds tracked by Wall St. Rank held ESSA Pharma as of Q2 2022.

Based on Credit Suisse's 13F filing for Q2 2022, filed 12 Aug 2022.